Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 8—August 2023
Research Letter

Asymptomatic Healthcare Worker PCR Screening during SARS-CoV-2 Omicron Surge, Germany, 2022

Author affiliations: Paracelsus Medical University, Nuremberg, Germany (R. Bertram, J. Steinmann); Paracelsus Medical University, Salzburg, Austria (W. Hitzl); Ruhr University Bochum, Bochum, Germany (E. Steinmann)

Cite This Article

Abstract

During 2022, a total of 9,515 asymptomatic healthcare workers of a large hospital in Germany underwent SARS-CoV-2 PCR screening twice weekly. Of 398,784 saliva samples, 3,555 (0.89%) were PCR positive (median cycle threshold value 30). Early identification of infected healthcare workers can help reduce SARS-CoV-2 transmission in the hospital environment.

COVID-19, caused by the SARS-CoV-2 virus, results in acute pulmonary and extrapulmonary manifestations and frequently causes long-term sequalae (1). In Germany, ≈38.5 million SARS-CoV-2 infections and ≈174,000 COVID-19 deaths had been reported through May 2023 (2). Among those, ≈30.2 million infections and ≈47,000 deaths occurred during 2022, when SARS-CoV-2 Omicron variant dominance was accompanied by a mean hospitalization incidence of 5.87 (2). SARS-CoV-2 infection rates among hospitalized patients were reported to be ≈10%–15% (3). Healthcare workers (HCWs) also were exposed to an elevated risk of acquiring and shedding SARS-CoV-2 infections (4). Regular SARS-CoV-2 testing of asymptomatic HCWs has been found to reduced viral transmission to patients and coworkers (5). We report data from a systematic SARS-CoV-2 PCR screening program comprising >9,500 HCWs in a large hospital in Germany during 2022.

Klinikum Nürnberg is a tertiary care hospital with 2,233 beds at 2 sites in Nuremberg, Germany, and cares for ≈100,000 inpatients and ≈170,000 outpatients per year. During January–November 2022, all 9,515 hospital staff were instructed to participate in a government-mandated regular SARS-CoV-2 PCR screening program. According to federal law in Germany, participation was mandatory irrespective of the level of working exposure risk or vaccination status (Table; Appendix Table 1).

Asymptomatic HCWs collected saliva samples twice weekly via self-sampling using a reliable gargling method (6); part-time workers collected samples less frequently. Samples were subjected to PCR testing by an external provider, and turnaround time between sampling and electronic reporting was ≈24–38 h. However, staff with acute COVID-19 symptoms were immediately PCR tested in house. Persons with PCR-verified infection were quarantined for 5–7 days and excluded from the testing program for the next 10 weeks. In November 2022, hospital staff who had no direct patient contact discontinued the screening program.

Figure

Number of tests performed and positivity rates for healthcare worker screening during SARS-CoV-2 Omicron surge, Germany, 2022. A) Total number of tests (gray bars) and number of positive tests (red line) per calendar week in 2022. B) Percentage positivity of each healthcare worker group in relation to total staff. Black bars indicate all staff; gray bars indicate the HCW groups. Misc., miscellaneous; NS, not statistically significant.

Figure. Number of tests performed and positivity rates for healthcare worker screening during SARS-CoV-2 Omicron surge, Germany, 2022. A) Total number of tests (gray bars) and number of positive tests (red...

A total of 398,784 PCR tests were performed, among which 3,555 (0.89%) were positive; 2,782 persons tested positive >1. The cumulative infection rate of all tested asymptomatic HCWs was 29.2%. We observed a minimum positivity rate (0.25%) during January 2022 and the highest numbers of positive tests in March (1.89%) and October (1.69%) 2022 (Figure, panel A). The median cycle threshold (Ct) value of all positive PCR tests was 30 (interquartile range [IQR] 27–32), suggesting that SARS-CoV-2–positive staff were detected at an early phase of infection. Asymptomatic HCWs who tested SARS-CoV-2–positive frequently had symptoms develop a few days after detection, accompanied by lower Ct values (data not shown).

We categorized hospital staff into 5 groups: physicians, nurses, facility services, administration, and miscellaneous. Physicians constituted 13.4% of hospital staff and showed an infection rate of 13.6%. According to contingency table analysis, that rate results in a relative risk (RR) for infection of 1.02 (95% CI 0.91–1.14; p = 0.77 by Fisher exact test). Nurses accounted for 37.2% of hospital staff and exhibited an infection rate of 37.4% resulting in an RR for infection of 1.01 (95% CI 0.95–1.07; p = 0.81 by Fisher exact test). Thus, despite having the most intense contact with patients, neither of the 2 groups was significantly overrepresented in infection events (Figure, panel B; Appendix Table 1).

This 12-month SARS-CoV-2 PCR screening surveillance program of asymptomatic HCWs resulted in an average positivity rate of 0.89%. A meta-analysis of data from January–August 2020 collected by hospitals worldwide reported an average of 1.9% of asymptomatic HCWs tested PCR-positive for SARS-CoV-2 (7). We detected 3,555 COVID-19 cases among 2,782 (29.2%) HCWs infected >1 time. That number corresponds to results from another 12-month study in South Africa encompassing medical laboratory staff that had an overall cumulative infection rate of 25.7% (8). Comparisons warrant caution because of different spatiotemporal dominance of SARS-CoV-2 variants; vaccination status of HCWs, considering lower efficacy of vaccines against Omicron (9); and different infection control measures applied among hospitals (10). Furthermore, the surveillance study we report was not a randomized controlled trial, does not provide data on asymptomatic courses or rates of false positive PCR results, nor does it provide detailed information regarding seroprevalence or symptoms that developed.

The finding that physicians and nurses who were at the frontline of the COVID-19 outbreak response at Klinikum Nürnberg were not overrepresented in infection numbers speaks in favor of an efficient hygiene regimen. Besides measures such as compulsory patient screening, high-quality protective equipment, or regular ventilation, we believe that effective identification of asymptomatic HCWs in a preinfectious status might be one cornerstone of SARS-CoV-2 infection prevention in hospitals.

Dr. Ralph Bertram is a microbiologist and a researcher and lecturer in the Institute of Clinical Hygiene, Medical Microbiology and Infectiology, Klinikum Nürnberg, Paracelsus Medical University, Nuremberg, Germany. His research interests focus on infectious diseases, drug insensitivity of nosocomial pathogens and gene regulation.

Top

Acknowledgment

We thank Johanna Zeller and Florian Engelhardt for their support with data acquisition, Sabine Davison for proofreading and editing English, and the Paracelsus Medical University for their support.

Top

References

  1. Nalbandian  A, Sehgal  K, Gupta  A, Madhavan  MV, McGroder  C, Stevens  JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:60115. DOIPubMedGoogle Scholar
  2. Robert Koch-Institut. COVID-19: case numbers in Germany and worldwide [in German]. 2022 [cited 2023 May 29]. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/nCoV.html
  3. Barranco  R, Vallega Bernucci Du Tremoul  L, Ventura  F. Hospital-acquired SARS-Cov-2 infections in patients: inevitable conditions or medical malpractice? Int J Environ Res Public Health. 2021;18:489. DOIPubMedGoogle Scholar
  4. World Health Organization. Health workers exposure risk assessment and management in the context of COVID-19 virus: interim guidance, 4 March 2020 [cited 2023 Jan 30]. https://apps.who.int/iris/handle/10665/331340
  5. Viswanathan  M, Kahwati  L, Jahn  B, Giger  K, Dobrescu  AI, Hill  C, et al. Universal screening for SARS-CoV-2 infection: a rapid review. Cochrane Database Syst Rev. 2020;9:CD013718.PubMedGoogle Scholar
  6. Butler-Laporte  G, Lawandi  A, Schiller  I, Yao  M, Dendukuri  N, McDonald  EG, et al. Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis. JAMA Intern Med. 2021;181:35360. DOIPubMedGoogle Scholar
  7. Jabs  JM, Schwabe  A, Wollkopf  AD, Gebel  B, Stadelmaier  J, Erdmann  S, et al. The role of routine SARS-CoV-2 screening of healthcare-workers in acute care hospitals in 2020: a systematic review and meta-analysis. BMC Infect Dis. 2022;22:587. DOIPubMedGoogle Scholar
  8. Wilson  KS, Ntlebi  V, Made  F, Sanabria  N, Vetten  M, Joseph  J, et al. COVID-19 cases among medical laboratory services staff in South Africa, 2020-2021: A cohort study. PLoS One. 2022;17:e0268998. DOIPubMedGoogle Scholar
  9. Ren  SY, Wang  WB, Gao  RD, Zhou  AM. Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance. World J Clin Cases. 2022;10:111. DOIPubMedGoogle Scholar
  10. Jin  H, Chen  Y, Fu  Q, Qu  Q. Occupational risk factors of contracting COVID-19 among health workers: A systematic review. Work. 2021;69:72134. DOIPubMedGoogle Scholar

Top

Figure
Table

Top

Cite This Article

DOI: 10.3201/eid2908.230156

Original Publication Date: June 23, 2023

Table of Contents – Volume 29, Number 8—August 2023

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Joerg Steinmann, Paracelsus Medical University, Prof.-Ernst-Nathan-Str. 1, Nuremberg 90419, Germany

Send To

10000 character(s) remaining.

Top

Page created: June 13, 2023
Page updated: July 20, 2023
Page reviewed: July 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external